The Board of Directors of HealthCare Global Enterprises Limited approved a proposal to issue fully paid-up equity shares worth up to ₹4,250 Crore through a rights issue. This decision, made during the meeting on February 17, 2026, is aimed at raising substantial capital. The final terms, including the issue price and entitlement ratio, will be decided by the Rights Issue Committee and disclosed later, subject to required regulatory approvals.
HCG Board Approves Significant Capital Raise
During the Board of Directors meeting held on February 17, 2026, HealthCare Global Enterprises Limited (the Company) approved a major initiative to raise capital through a rights issue of its fully paid-up equity shares. The face value of these proposed Equity Shares is set at ₹10 each.
Issue Size and Scope
The total value of the proposed issuance is set not to exceed ₹42,500 Lakhs (Rupees Forty Two Thousand and Five Hundred Lakhs), which is equivalent to ₹4,250 Crore. The rights issue will be offered to the eligible equity shareholders of the Company as on a record date that will be determined and announced subsequently.
Key Decision Making Delegated
The Board has reserved the right to determine the specific and detailed terms necessary to implement the rights issue effectively. These crucial parameters include, but are not limited to, the issue price, the rights entitlement ratio, the record date, the timing of the issue, and the terms of payment. These specifics will be determined by the Board or the Rights Issue Committee authorized for this purpose and will be disclosed to the stock exchange in due course.
Meeting Details
The Board meeting commenced proceedings at 5 p.m. and concluded at 7:25 p.m. on the day of the announcement.
Summary of Issuance Details (Annexure A)
The proposed issuance is structured as a Rights issue directed specifically to the eligible equity shareholders as of the determined record date. The total amount for which the securities will be issued is approximately ₹4,250 Crore. All other disclosure points related to preferential allotment, bonus issues, depository receipts (ADR/GDR), or debt securities issuance were confirmed as Not Applicable for this specific action.
Source: BSE
